References
- Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howeard R, et al. Amyotrophic lateral sclerosis in south-aast England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology. 2006; 29: 44–8
- Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J Clin Invest. 2005; 115: 1449–57
- Talbot K, Ansorge O. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. Hum Mol Genet. 2006; 15: 182–7
- Phukan J, Pender N, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurol. 2007; 6: 994–1003
- Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology. 1999; 52: 504–9
- O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008; 79: 30–2
- Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 1990; 46: 222–8
- Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, et al French research network on FTD/FTD-MND. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain. 2008;131:732–46. Epub 2008, Feb 1.
- Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van Vught PW. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology. 2008 ( Epub ahead of print).
- Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia and Parkinson's disease: evidence of shared genetic susceptibility. Neurology. 1994; 44: 1872–7